Invitation to Contribute to the European Journal of Nanomedicine
-
Karin Lason
Dear Friends of Nanomedicine,
Having been successfully relaunched in 2012 by the academic publisher De Gruyter in close cooperation with the CLINAM, the European Journal of Nanomedicine (EUJNM) provides its readers with novelties in general and basic Nanomedicine publishing clinically focused research for the benefit of patients. We would hereby like to kindly invite you to contribute to our journal.
The peer-reviewed quarterly EUJNM issues includes Reviews, Original Research Articles, Case Reports, Short Communications and Letters. We offer rapid editorial evaluation and short publication times without compromising on scientific quality. Outstanding papers will be freely accessible by Editor’s choice. We would like to emphasize that there will be no page charges, and no charges for color illustrations. Accepted papers are published ahead of print in an accelerated online-only format for immediate visibility within the scientific community. Manuscript submission and peer review is done online via ScholarOne (Thomson Reuters) at http://mc.manuscriptcentral.com/eujnm.
Of course, we will be happy to provide you with any assistance during the submission and publication process. We would expect your contribution by the end of March if that is feasible for you.
For further information, please have a look at the journal’s website www.degruyter.com/view/j/ejnm and do not hesitate to contact us at our Editorial Office (editorial.nanomedicine@degruyter.com).
We would be honored to receive a positive reply from you and look forward to your feedback on our proposal. Thank you for your support.
Sincerely and with kind regards from Berlin
Editor-in-Chief:
Patrick Hunziker, Basel, Switzerland
Managing Editor:
Beat Löffler, Basel, Switzerland
Editors:
Christoph Alexiou, Erlangen, Germany
Yechezkel Barenholz, Jerusalem, Israel
Andreas Jordan, Berlin, Germany
Claus-Michael Lehr, Saarbrücken, Germany
Jan Mollenhauer, Odense, Denmark
Bert Müller, Basel, Switzerland
Giacinto Scoles, Trieste, Italy
Janos Szebeni, Budapest, Hungary
Editorial Advisory Board:
Lajos Balogh, Boston, USA
Massimiliano Papi, Rome, Italy
©2012 by Walter de Gruyter Berlin Boston
Articles in the same Issue
- Masthead
- Masthead
- Editorials
- “Widespread orphan diseases” – A call for research, development strategies, and regulatory pathways for frequent diseases with multiple molecularly defined subgroups
- Editorial
- Reviews
- Breast cancer stem cells: a moving target for cancer nanomedicine
- Why not just switch on the light?: light and its versatile applications in the field of nanomedicine
- Original Article
- HIV-specific immunotherapy with DermaVir, the first pDNA/PEIm pathogen-like nanomedicine
- Opinion Paper
- Limitations and niches of the active targeting approach for nanoparticle drug delivery
- Letter to the Editor
- NanoMed 2020 – Enabling the European nanomedicine area until 2020
- Call for Papers
- Invitation to Contribute to the European Journal of Nanomedicine
Articles in the same Issue
- Masthead
- Masthead
- Editorials
- “Widespread orphan diseases” – A call for research, development strategies, and regulatory pathways for frequent diseases with multiple molecularly defined subgroups
- Editorial
- Reviews
- Breast cancer stem cells: a moving target for cancer nanomedicine
- Why not just switch on the light?: light and its versatile applications in the field of nanomedicine
- Original Article
- HIV-specific immunotherapy with DermaVir, the first pDNA/PEIm pathogen-like nanomedicine
- Opinion Paper
- Limitations and niches of the active targeting approach for nanoparticle drug delivery
- Letter to the Editor
- NanoMed 2020 – Enabling the European nanomedicine area until 2020
- Call for Papers
- Invitation to Contribute to the European Journal of Nanomedicine
